Omega-3 fatty acids in the treatment of psychiatric disordersMalcolm Peet
Swallownest Court Hospital, Doncaster and South Humber Healthcare NHS Trust, Sheffield, UK
Drugs 65:1051-9. 2005
..However, as the clinical research evidence is preliminary, large, and definitive randomised controlled trials similar to those required for the licensing of any new pharmacological treatment are needed...
- A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
Malcolm Peet
Swallownest Court, Aughton Road, S26 4TH, Sheffield, UK
J Psychiatr Res 36:7-18. 2002
..This effect was greatest at 2 g/day. There was a positive relationship between improvement on rating scales and rise in red blood cell arachidonic acid concentration...
- Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms
Caroline Stokes
Rotherham Mental Health Services, Swallownest Court, Sheffield, S26 4TH, UK
Nutr Neurosci 7:247-9. 2004
..54, p = 0.02) and this was independent of the effect of medication. This finding is consistent with earlier studies...
- Nutrition and schizophrenia
Malcolm Peet
Doncaster and South Humber NHS Trust, Sheffield, UK
World Rev Nutr Diet 95:17-28. 2005
- Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia
Malcolm Peet
Swallownest Court Hospital, Sheffield, Great Britain
Isr J Psychiatry Relat Sci 45:19-25. 2008
..However, such approaches have been little evaluated in mental health....
- The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia
Malcolm Peet
Doncaster and South Humber Healthcare NHS Trust, Rotherham Services, Early Intervention Service, Swallownest, Sheffield, S26 4TH, UK
Prostaglandins Leukot Essent Fatty Acids 75:323-7. 2006
..The associations may derive either from genetic or from environmental factors, including nutrition. Further investigation of these associations may give important clues regarding the aetiology of schizophrenia...
- Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients
Malcolm Peet
Rotherham Mental Health Services, Swallownest Court, Aughton Road, Sheffield, S26 4TH, UK
World J Biol Psychiatry 5:92-9. 2004
....
- International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis
Malcolm Peet
Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
Br J Psychiatry 184:404-8. 2004
..Dietary variations are known to predict the prevalence of physical illnesses such as diabetes and heart disease but the possible influence of diet on mental health has been neglected...
- Nutrition and schizophrenia: beyond omega-3 fatty acids
Malcolm Peet
Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
Prostaglandins Leukot Essent Fatty Acids 70:417-22. 2004
....
- Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results
Malcolm Peet
Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
Prostaglandins Leukot Essent Fatty Acids 69:477-85. 2003
....
- A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
Malcolm Peet
Swallownest Court Hospital, Sheffield, England
Arch Gen Psychiatry 59:913-9. 2002
..CONCLUSION: Treatment with ethyl-eicosapentaenoate at a dosage of 1 g/d was effective in treating depression in patients who remained depressed despite adequate standard therapy...
- Diet, diabetes and schizophrenia: review and hypothesis
Malcolm Peet
Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
Br J Psychiatry Suppl 47:S102-5. 2004
..Diabetes is more common in people with schizophrenia than in the general population...
- Nutrition and schizophrenia: an epidemiological and clinical perspective
Malcolm Peet
Nutr Health 17:211-9. 2003
..These findings suggest a new paradigm for our understanding of the causation and treatment of schizophrenia...
- Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
Marlene P Freeman
Women s Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724 5002, USA
J Clin Psychiatry 67:1954-67. 2006
..To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders...
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorderShima Jazayeri
Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Aust N Z J Psychiatry 42:192-8. 2008
..To compare therapeutic effects of eicosapentaenoic acid (EPA), fluoxetine and a combination of them in major depression...
